Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine

被引:36
作者
Amic, Fedor [1 ,2 ]
Drmic, Domagoj [1 ,2 ]
Bilic, Zdenko [1 ,2 ]
Krezic, Ivan [1 ,2 ]
Zizek, Helena [1 ,2 ]
Peklic, Marina [1 ,2 ]
Klicek, Robert [1 ,2 ]
Pajtak, Alen [1 ,2 ]
Amic, Enio [1 ,2 ]
Vidovic, Tinka [1 ,2 ]
Raklc, Mlslav [1 ,2 ]
Perisa, Marija Milkovic [1 ,2 ]
Pavlov, Katarina Horvat [1 ,2 ]
Kokot, Antonio [1 ,2 ]
Tvrdeic, Ante [1 ,2 ]
Blagaic, Alenka Boban [1 ,2 ]
Zovak, Mario [1 ,2 ]
Seiwerth, Sven [1 ,2 ]
Sikiric, Predrag [1 ,2 ]
机构
[1] Univ Zagreb, Med Fac, Dept Pharmacol, Salata 11,POB 916, Zagreb 10000, Croatia
[2] Univ Zagreb, Med Fac, Dept Pathol, Zagreb 10000, Croatia
关键词
Major venous occlusion; Duodenal lesions; BPC; 157; L-NAME; Bypassing; L-arginine; Reduction of free radical formation; Rats; ADAPTIVE CYTOPROTECTION; STOMACH; ANGIOGENESIS; CYSTEAMINE; COLITIS; ETHANOL; STRESS; ULCER; ORGANIZATION; GRANULATION;
D O I
10.3748/wjg.v24.i47.5366
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To investigate whether duodenal lesions induced by major venous occlusions can be attenuated by BPC 157 regardless nitric oxide (NO) system involvement. METHODS Male Wistar rats underwent superior anterior pancreaticoduodenal vein (SAPDV)-ligation and were treated with a bath at the ligated SAPDV site (BPC 157 10 mu g, 10 ng/kg per 1 mL bath/rat; L-NAME 5 mg/kg per 1 mL bath/rat; L-arginine 100 mg/kg per 1 mL bath/rat, alone and/or together; or BPC 157 10 mu g/kg instilled into the rat stomach, at 1 min ligation-time). We recorded the vessel presentation (filled/appearance or emptied/disappearance) between the 5 arcade vessels arising from the SAPDV on the ventral duodenum side, the inferior anterior pancreaticoduodenal vein (IAPDV) and superior mesenteric vein (SMV) as bypassing vascular pathway to document the duodenal lesions presentation; increased NO- and oxidative stress [malondialdehyde (MDA)]-levels in duodenum. RESULTS Unlike the severe course in the SAPDV-ligated controls, after BPC 157 application, the rats exhibited strong attenuation of the mucosal lesions and serosal congestion, improved vessel presentation, increased interconnections, increased branching by more than 60% from the initial value, the IAPDV and SMV were not congested. Interestingly, after 5 min and 30 min of L-NAME and L-arginine treatment alone, decreased mucosal and serosal duodenal lesions were observed; their effect was worsened at 24 h, and no effect on the collateral vessels and branching was seen. Together, L-NAME+L-arginine antagonized each other's response, and thus, there was an NO-related effect. With BPC 157, all SAPDV-ligated rats receiving L-NAME and/or L-arginine appeared similar to the rats treated with BPC 157 alone. Also, BPC 157 in SAPDV-ligated rats normalized levels of NO and MDA, two oxidative stress markers, in duodenal tissues. CONCLUSION BPC 157, rapidly bypassing occlusion, rescued the original duodenal flow through IAPDV to SMV flow, an effect related to the NO system and reduction of free radical formation.
引用
收藏
页码:5366 / 5378
页数:13
相关论文
共 50 条
[21]  
Mise S, 2006, MED SCI MONITOR, V12, pBR146
[22]   An overview of acetic acid ulcer models - The history and state of the art of peptic ulcer research [J].
Okabe, S ;
Amagase, K .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (08) :1321-1341
[23]   PROSPECTS FOR TREATMENT OF FREE RADICAL-MEDIATED TISSUE-INJURY [J].
RANGAN, U ;
BULKLEY, GB .
BRITISH MEDICAL BULLETIN, 1993, 49 (03) :700-718
[24]   Structural adaptations in the murine colon microcirculation associated with hapten-induced inflammation [J].
Ravnic, Dino J. ;
Konerding, Moritz A. ;
Tsuda, Akira ;
Huss, Harold T. ;
Wolloscheck, Tanja ;
Pratt, Juan P. ;
Mentzer, Steven J. .
GUT, 2007, 56 (04) :518-523
[25]   CYTOPROTECTION BY PROSTAGLANDINS [J].
ROBERT, A .
GASTROENTEROLOGY, 1979, 77 (04) :761-767
[26]   ANTIOXIDANT THERAPY [J].
SCHILLER, HJ ;
REILLY, PM ;
BULKLEY, GB .
CRITICAL CARE MEDICINE, 1993, 21 (02) :S92-S102
[27]   BPC 157 and Blood Vessels [J].
Seiwerth, Sven ;
Brcic, Luka ;
Vuletic, Lovorka Batelja ;
Kolenc, Danijela ;
Aralica, Gorana ;
Misic, Marija ;
Zenko, Anita ;
Drmic, Domagoj ;
Rucman, Rudolf ;
Sikiric, Predrag .
CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (07) :1121-1125
[28]   Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response. [J].
P. Sikiric ;
S. Seiwerth ;
L. Brcic ;
A. B. Blagaic ;
I. Zoricic ;
M. Sever ;
R. Klicek ;
B. Radic ;
N. Keller ;
K. Sipos ;
A. Jakir ;
M. Udovicic ;
A. Tonkic ;
N. Kokic ;
B. Turkovic ;
S. Mise ;
T. Anic .
InflammoPharmacology, 2006, 14 (5-6) :214-221
[29]   Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157 [J].
Sikiric, P. ;
Seiwerth, S. ;
Rucman, R. ;
Turkovic, B. ;
Rokotov, D. S. ;
Brcic, L. ;
Sever, M. ;
Klicek, R. ;
Radic, B. ;
Drmic, D. ;
Ilic, S. ;
Kolenc, D. ;
Stambolija, V. ;
Zoricic, Z. ;
Vrcic, H. ;
Sebecic, B. .
CURRENT MEDICINAL CHEMISTRY, 2012, 19 (01) :126-132
[30]   The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation [J].
Sikiric, P ;
Separovic, J ;
Anic, T ;
Buljat, G ;
Mikus, D ;
Seiwerth, S ;
Grabarevic, Z ;
Stancic-Rokotov, D ;
Pigac, B ;
Hanzevacki, M ;
Marovic, A ;
Rucman, R ;
Petek, M ;
Zoricic, I ;
Ziger, T ;
Aralica, G ;
Konjevoda, P ;
Prkacin, I ;
Gjurasin, M ;
Miklic, P ;
Artukovic, B ;
Tisljar, M ;
Bratulic, M ;
Mise, S ;
Rotkvic, I .
JOURNAL OF PHYSIOLOGY-PARIS, 1999, 93 (06) :479-485